GHK-Cu and skin: research on wrinkles and collagen

The human evidence base is limited and concerns skin creams and other products applied to the skin. We have not found any study that tested GHK-Cu alone against placebo in humans over a longer period.

The most thorough one is a study published in 2026 in Skin Research and Technology. In it, 32 adults with sensitive skin aged 30 to 57 applied the same facial cream twice daily for 56 days. The cream contained both 5 percent fermentation extract and 0.2 percent GHK-Cu.

After 56 days, the dermatologists' assessment scores had fallen by 16.75 percent for forehead lines and by 8.68 percent for cheek wrinkles compared with baseline. A lower score means milder assessed wrinkles. For under-eye wrinkles and nasolabial folds the dermatologist assessments showed no statistically significant improvement, while instrument measurements showed improvements in some readings, including reduced water loss through the skin and higher moisture content in the outer skin layer.

Here is how the results should be read: all participants received the same cream, there was no control group and no placebo, two participants dropped out, the study period was eight weeks, and the work was carried out by researchers at a cosmetics company. The cream also contained two active ingredients. The effect of GHK-Cu alone cannot therefore be established, and the results concern that specific cream, not the research product sold in the shop.

An older study published in 2006 in Archives of Facial Plastic Surgery examined skincare products with GHK-Cu in patients who had undergone CO2 laser resurfacing. It was small, short term, and showed no clear benefit that can be generalized to ordinary skincare. Negative and unclear results are also part of the overall picture.

GHK is a tripeptide, meaning a chain of three amino acids: glycine, histidine and lysine. It occurs naturally in human blood plasma.

GHK binds copper ions to form the complex GHK-Cu. Copper is a trace element needed by several enzymes, including ones that stabilize collagen. The hyphen in GHK-Cu marks that copper complex specifically.

In a cell study published in 1988 in FEBS Letters, the researchers reported that GHK-Cu increased collagen synthesis in cultured fibroblasts. Fibroblasts are the cells in the skin that produce connective tissue.

That is a clear result, but it applies to cells in a culture dish. Human skin has blood flow, an immune system, a protective outer layer and a completely different environment.

Later reviews, including one published in 2015 in BioMed Research International, describe GHK as a modulator of several cellular signaling pathways in skin regeneration. Reviews summarize existing research and do not count as new evidence.

The 2026 study also included laboratory sections in which the combination dampened inflammatory signals in cultured immune cells and protected skin samples against UV damage. These are cell experiments and tissue experiments, not measurements in living humans.

The proposed mechanism is that the complex delivers copper to cells while also affecting signaling pathways that govern connective tissue production and repair.

The collagen stimulation has been measured in cell culture. Whether the same thing happens in living skin to a meaningful extent is a hypothesis that the current human studies cannot settle.

There are clear cellular effects, small human studies of topical products, and no strong chain of evidence connecting the two.

GHK-Cu is a copper-binding tripeptide that has increased collagen synthesis in cell culture.

In humans there are small studies of creams. The most thorough one, from 2026, measured reduced forehead and cheek wrinkles and improved skin barrier after 56 days, but lacked a control group and tested a cream with two active ingredients.

The evidence base is therefore not enough to establish what GHK-Cu alone does to the skin, and cream results do not apply to other formulations.